CMDE Issues New Battery Registration Guidance for Active Implantable Medical Devices
Regulatory Update | November 2026
Battery performance is critical to the safety and reliability of active implantable medical devices. For products like cardiac pacemakers, cochlear implants, and implantable neurostimulators, a battery failure can directly affect device performance — and, in some cases, patient safety.
Recognising this, China's Center for Medical Device Evaluation (CMDE) issued the Guiding Principles for Registration Review of Batteries for Active Implantable Medical Devices on 8 October 2026, under Announcement No. 27 of 2026.
The guidance gives applicants and reviewers a framework for preparing and assessing battery-related registration documentation, covering battery design, performance, risk management, nonclinical evidence, safety requirements, and labelling. For manufacturers seeking registration in China, the message is clear: treat battery documentation as an integral part of the overall registration dossier.
Understanding the New Guidance
The guidance applies to batteries used in active implantable medical devices such as cardiac pacemakers, cochlear implants, and implantable neurostimulators. It covers several battery technologies:
Category | Examples |
Chemical batteries | Lithium-ion, nickel-metal hydride, nickel-cadmium, lead-acid, dry-cell |
Physical batteries | Including photovoltaic cells |
Emerging technologies | Including flexible batteries |
Excluded: nuclear batteries and biofuel cells.
Although written for active implantable devices, the document notes that its general technical considerations may serve as a reference for batteries in other medical devices.
Important: the guidance supports applicants and technical reviewers; it is not a mandatory administrative approval requirement or an independently enforceable regulation. Applicants may use alternative approaches if they can provide sufficient research and validation evidence demonstrating compliance with the applicable regulatory requirements.
What Must Be Addressed in Registration Documentation?
A key emphasis is consistency. Battery information should be presented coherently across the relevant dossier sections: regulatory information, product overview, nonclinical documentation, instructions for use, and labelling. Four areas stand out.
1. Battery Design and Specifications
Describe the battery technology, cell and pack configurations, design characteristics, and technical specifications. Depending on the device, this may include dimensions, nominal voltage, capacity, energy density, power density, charging and discharging capabilities, and operating temperature ranges.
If a battery-management system or protection circuit is used, explain its main functions, operating principles, and protective mechanisms.
2. Battery-Related Risk Management
The guidance emphasises identifying and managing battery hazards across the device lifecycle, including:
Battery leakage and potential chemical damage
Overheating from internal short circuits or other failures
Fire from thermal runaway
Explosion and associated harm to patients or equipment
Battery depletion or loss of service life that prevents the device from operating as intended
Identify the hazards, evaluate their consequences, implement risk controls, and provide evidence that those controls work. Also consider environmental conditions: temperature, humidity, altitude, pressure, vibration, electromagnetic environments, and radiation exposure that can affect battery safety and performance.
3. Nonclinical Testing and Supporting Evidence
Provide technical evidence for the battery's safety, reliability, and performance within the intended device application. Relevant assessment areas include:
Battery discharge characteristics
Battery life-cycle testing
Protection-circuit performance
Battery safety
For rechargeable batteries, also consider charging and discharging conditions and how repeated cycles affect capacity. Third-party certification and supplier reliability information may support your submission where relevant.
4. Instructions for Use and Labelling
Reflect battery-related safety information in instructions for use and labelling: hazards, usage limitations, warnings, emergency measures, and precautions.
Where patient safety depends on an internal power supply, the device should be able to detect battery status and alert users when capacity is insufficient. For rechargeable batteries, instructions should explain how users can check remaining charge and when to recharge or replace.
Why This Matters for International Manufacturers
The guidance offers a clearer technical framework for preparing battery documentation for the Chinese market, especially relevant for companies sourcing batteries from third-party suppliers.
Even when a battery is made externally, the device manufacturer remains responsible for a complete, consistent registration dossier. That requires sufficient technical information on battery cells, pack design, manufacturing controls, testing, and reliability.
If supplier documentation is incomplete, or information differs across the dossier, applicants may face additional questions during technical review. Establish clear communication and documentation arrangements with battery suppliers before submitting.
What Manufacturers Should Do Now
1. Review existing registration documentation. Check that battery specifications, design information, and performance evidence are adequately represented throughout the dossier.
2. Strengthen supplier coordination: Confirm suppliers can provide the technical information, test reports, and reliability evidence needed to support the finished-device application.
3. Reassess battery-related risks: Make sure your risk-management file covers battery-specific hazards, device integration, and relevant environmental conditions.
4. Evaluate nonclinical evidence: Check that existing testing adequately supports discharge performance, service life, protection mechanisms, and safety under intended operating conditions.
5. Review instructions for use and labelling. Ensure battery warnings, limitations, status indicators, and charging or replacement instructions are properly addressed.
Special attention: if your application was prepared using the draft principles released for consultation in December 2022, assess your documentation against the final guidance and close any gaps before submitting or updating an NMPA application.
ARQon Insight
Dedicated battery guidance highlights the growing importance of component-level evidence in medical-device registration.
Battery compliance isn't just about showing that a component meets its own specifications. It's about showing how that component performs within the finished device, how associated risks are controlled, and how safety is maintained across the product lifecycle.
This matters most for international manufacturers relying on external battery suppliers, where access to complete, consistent technical documentation can shape registration preparation.
Key Takeaway
China's new CMDE guidance provides a more structured framework for battery-related requirements in active implantable device registrations.
Review your battery specifications, supplier documentation, risk-management evidence, nonclinical testing, and labelling to make sure they're adequately addressed and consistent across the dossier.
For China, a strong battery story starts with the supplier and ends with a consistent dossier.
How ARQon Can Support You
At ARQon, we support healthcare companies navigating international regulatory requirements through:
Regulatory intelligence
Registration support
Technical documentation planning
Market-access guidance
Stay Ahead. Stay Compliant. Stay Informed. With ARQon Regulatory Intelligence.
Official and Supporting Sources
Center for Medical Device Evaluation (CMDE): Guiding Principles for Registration Review of Batteries for Active Implantable Medical Devices, Announcement No. 27 of 2026, issued 8 October 2026. Official guidance listing – CMDE Yangtze River Delta Branch
Regulatory guidance text: 有源植入式医疗器械电池注册审查指导原则. Read the Chinese guidance text
.png)




Comments